Utility of glycated hemoglobin screening in patients undergoing elective coronary artery surgery: Prospective, cohort

Francesco Nicolini1, Giuseppe Santarpino2, Giuseppe Gatti3

  • 1Division of Cardiac Surgery, University of Parma, Parma, Italy.

Insights

Elevated glycated hemoglobin (HbA1c) levels in patients undergoing coronary artery bypass grafting (CABG) predict sternal wound infection (SWI). Preoperative HbA1c screening is valuable for identifying diabetic patients at risk of SWI.

Area of Science:

  • Cardiovascular Surgery
  • Metabolic Health
  • Postoperative Complications

Background:

  • Increased glycated hemoglobin (HbA1c) is linked to higher sternal wound infection (SWI) risk post-coronary artery bypass grafting (CABG).
  • The impact of elevated HbA1c on other postoperative outcomes remains unclear.

Purpose of the Study:

  • To investigate the association between preoperative HbA1c levels and various postoperative outcomes in patients undergoing elective CABG.
  • To determine the predictive value of HbA1c for SWI and other complications.

Main Methods:

  • Prospective, multicenter E-CABG registry data from 2606 patients undergoing elective isolated CABG (2015-2016).
  • Collection and analysis of preoperative HbA1c levels.
  • Multilevel mixed-effects logistic regression analysis to adjust for center-specific effects.

Main Results:

  • A significant proportion of patients had elevated HbA1c (≥53 mmol/mol or 7.0%), particularly those with diabetes (53.5% non-insulin dependent, 67.1% insulin dependent).
  • Baseline HbA1c ≥53 mmol/mol (7.0%) was a significant predictor of any SWI (10.7% vs. 3.3%), deep SWI/mediastinitis (3.8% vs. 1.3%), and acute kidney injury (27.4% vs. 19.8%).
  • Among diabetic patients, HbA1c ≥53 mmol/mol (7.0%) predicted SWI (11.1% vs. 4.8%).

Conclusions:

  • Elevated HbA1c is prevalent in CABG patients and associated with increased SWI risk.
  • Preoperative HbA1c screening is recommended for identifying diabetic patients at higher risk of SWI.
  • Results do not support routine HbA1c screening in non-diabetic patients undergoing CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
8.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734